GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Achiko AG (XSWX:ACHI) » Definitions » YoY EBITDA Growth

Achiko AG (XSWX:ACHI) YoY EBITDA Growth : 63.16% (As of Jun. 2022)


View and export this data going back to 2019. Start your Free Trial

What is Achiko AG YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Achiko AG's YoY EBITDA Growth for the quarter that ended in Jun. 2022 was 63.16%.

Achiko AG's EBITDA per Share for the six months ended in Jun. 2022 was CHF-0.01.

Achiko AG YoY EBITDA Growth Historical Data

The historical data trend for Achiko AG's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achiko AG YoY EBITDA Growth Chart

Achiko AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21
YoY EBITDA Growth
- - -54.43 51.64

Achiko AG Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
YoY EBITDA Growth Get a 7-Day Free Trial -341.67 -16.67 28.30 68.57 63.16

Achiko AG YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Achiko AG's YoY EBITDA Growth for the fiscal year that ended in Dec. 2021 is calculated as:

YoY EBITDA Growth (A: Dec. 2021 )
=(EBITDA per Share (A: Dec. 2021 )-EBITDA per Share (A: Dec. 2020 ))/ | EBITDA per Share (A: Dec. 2020 ) |
=(-0.059--0.122)/ | -0.122 |
=51.64 %

Achiko AG's YoY EBITDA Growth for the quarter that ended in Jun. 2022 is calculated as:

YoY EBITDA Growth (Q: Jun. 2022 )
=(EBITDA per Share (Q: Jun. 2022 )-EBITDA per Share (Q: Jun. 2021 )) / | EBITDA per Share (Q: Jun. 2021 )) |
=(-0.014--0.038)/ | -0.038 |
=63.16 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Achiko AG YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Achiko AG's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Achiko AG (XSWX:ACHI) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Achiko AG (XSWX:ACHI) » Definitions » YoY EBITDA Growth
Comparable Companies
SZSE:300869 SZSE:300314 SZSE:300246 SZSE:300633 SZSE:301033 SZSE:300813 SHSE:688016 SZSE:300206 SZSE:301235 SHSE:688389 CERN VEEV TSE:2413 CHNG DOCS NUTX RCM TDOC TXG HQY
Traded in Other Exchanges
N/A
Address
Tessinerplatz 7, Zurich, CHE, CH-8002
Website
https://www.achiko.com
Achiko AG is developing disruptive diagnostic solutions that put people first. The company product is a rapid, reliable Covid-19 test with a companion app offering a user-friendly digital health passport. Achiko creates and develops aptamer-based diagnostics through its biotechnology division, AptameX, and companion health apps via its digital mobile health technology division, Teman Sehat. The AptameX DNA aptamer tests can be rapidly chemically synthesized, are cost-effective, and have wide potential across multiple disease diagnostics. Leveraging AptameX and Teman Sehat, Achiko aims to deliver fast, accurate, and affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications in the rapidly evolving healthcare diagnostics field.

Achiko AG (XSWX:ACHI) Headlines

No Headlines